Effects of Omega 3 in Hemodialysis Patients

Effets of Fish Oil on Metabolic Fate of an Oral Glucose Load in Patients With End Stage Renal Disease Undergoing Hemodialysis

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00431899

Enrollment

Registered

2007-02-06

Start date

2003-05-31

Completion date

2003-11-30

Last updated

2016-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Disease, Hemodialysis

Keywords

nutrition, omega 3 fatty acids, insulin resistance

Brief summary

The aim of the study was to determine the effects of a 3-week fish oil oral supplementation on the metabolic fate and thermogenic effect of an oral glucose load in hemodialysis patients.

Interventions

BEHAVIORALfish oil supplementation

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

SCREENING

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* hemodialysis at least 6 months duration end stage renal disease

Exclusion criteria

* \- Age \< 18 y ou \> 75 y * Hemodialysis \< 6 months * Diabetes, obesity * allergy to fish * Asthma * glucocorticoïds, propranolol,, Immunosuppressive drugs, Insulin, Somatostatin * erythropoïetin \< 3 months * Cancer * Hemoglobin \< 11 g/l * disease \< 1 month * pregnancy * respiratory insufficiency * intensive sport practice * refusal

Design outcomes

Primary

Measure	Time frame
plasma glucose utilization	—
glucose-induced thermogenesis	—

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026